Stay updated with breaking news from Co Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2023 Earnings Call Transcript August 10, 2023 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $0.24. Operator: Welcome to the Co-Diagnostics Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask […]
Co-Diagnostics, Inc. awarded funding for Co-Dx PCR Home Platform from NIH RADx Tech Program
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) saw a significant increase in short interest in July. As of July 15th, there was short interest totalling 766,900 shares, an increase of 13.6% from the June 30th total of 675,200 shares. Based on an average daily trading volume, of 116,800 shares, the short-interest ratio is currently 6.6 […]
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...